Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Trogarzonon Aug 29, 2023 3:42pm
129 Views
Post# 35610493

RE:RE:RE:RE:analysts and the rest of us....

RE:RE:RE:RE:analysts and the rest of us....Last time we went at 19 cents.. well the situation was dire and the company had 2.5M in sales.... now with 85M in sales for the next couple of years and technically still growing. Ok we had a bad Q2 thanks to a non-recurring event. Then 2 approved products and 2 pipeline candidates. One P3 ready and the other one with Fast Track designation. Ok then you have the dept net of cash on hand of what 40M.  I mean they can manage to scrape the few milluions they need to clear the 20M bar, be it trough a private placement or expense cuts.  After that they should be able to streach the terms of the loan somewhat. Soon they should make a profit and start trading on a multiple of that if the Earth is still round.  It's out of this f..g world we are standing at this bankrupcy level.. Has a profitable company ever went bankrupt.  Educate please.
<< Previous
Bullboard Posts
Next >>